Advertisement
Advertisement
U.S. markets close in 5 hours 47 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Beximco Pharmaceuticals Limited (R2WA.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
0.42000.0000 (0.00%)
As of 08:05AM CEST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in EUR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/3/2023
Current
3/31/202312/31/20229/30/2022
Market Cap (intraday)
550.36M549.13M586.31M748.79M
Enterprise Value
638.19M635.49M687.02M859.71M
Trailing P/E
4.964.655.795.99
Forward P/E
3.94N/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/A
Price/Sales (ttm)
0.580.580.821.02
Price/Book (mrq)
0.520.520.700.86
Enterprise Value/Revenue
0.020.070.070.09
Enterprise Value/EBITDA
0.090.410.350.39

Trading Information

Stock Price History

Beta (5Y Monthly) 0.70
52-Week Change 3-43.24%
S&P500 52-Week Change 313.12%
52 Week High 30.7700
52 Week Low 30.3820
50-Day Moving Average 30.4260
200-Day Moving Average 30.4555

Share Statistics

Avg Vol (3 month) 3148
Avg Vol (10 day) 3180
Shares Outstanding 5446.11M
Implied Shares Outstanding 61.32B
Float 8297.32M
% Held by Insiders 10.00%
% Held by Institutions 11.61%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.03
Forward Annual Dividend Yield 47.34%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 43.55
Payout Ratio 434.25%
Dividend Date 3N/A
Ex-Dividend Date 4Nov 17, 2022
Last Split Factor 21.1:1
Last Split Date 3Nov 23, 2020

Financial Highlights

Currency in BDT.

Fiscal Year

Fiscal Year Ends Jun 30, 2022
Most Recent Quarter (mrq)Mar 31, 2023

Profitability

Profit Margin 11.79%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)6.06%
Return on Equity (ttm)9.65%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)6.60%
Gross Profit (ttm)15.71B
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)0.0800
Quarterly Earnings Growth (yoy)-13.80%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)24.43%
Current Ratio (mrq)1.58
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement